Cargando…

Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial)

BACKGROUND: Major depressive disorder is a common debilitating illness that is the second leading contributor to the global burden of disease. Unfortunately, about 30 % of patients do not respond to adequate trials of antidepressants and/or psychotherapies. About 45–60 % of such treatment-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Finnegan, Martha, Ryan, Karen, Shanahan, Enda, Harkin, Andrew, Daly, Leslie, McLoughlin, Declan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153900/ https://www.ncbi.nlm.nih.gov/pubmed/27965856 http://dx.doi.org/10.1186/s40814-016-0080-0

Ejemplares similares

Ketamine as an adjunctive therapy for major depression - a randomised controlled pragmatic pilot trial (Karma-Dep Trial)
por: Gallagher, Bronagh, et al.
Publicado: (2022)

PBMC telomerase activity in depression and the response to electroconvulsive therapy
por: Ryan, Karen M., et al.
Publicado: (2021)

Study protocol for Ketamine as an adjunctive therapy for major depression (2): a randomised controlled trial (KARMA-Dep [2])
por: Jelovac, Ana, et al.
Publicado: (2023)

Blood plasma B vitamins in depression and the therapeutic response to electroconvulsive therapy
por: Ryan, Karen M., et al.
Publicado: (2020)

Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial
por: Fernie, Gordon, et al.
Publicado: (2017)

Usefulness of Hamilton rating scale for depression subset scales and full versions for electroconvulsive therapy
por: Fenton, Caoimhe, et al.
Publicado: (2021)

Effects of ketamine in electroconvulsive therapy for major depressive disorder: meta-analysis of randomised controlled trials
por: Li, Xiao-Mei, et al.
Publicado: (2020)

Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial
por: Anderson, Ian M, et al.
Publicado: (2017)

Ketamine and Electroconvulsive Therapy: Better Together?
por: Fraga, A., et al.
Publicado: (2022)

Comparative Effect of Intravenous Ketamine and Electroconvulsive Therapy in Major Depression: A Randomized Controlled Trial
por: Kheirabadi, Gholamreza, et al.
Publicado: (2019)

Antidepressant Effect of Combined Ketamine and Electroconvulsive Therapy on Patients With Major Depressive Disorder: A Randomized Trial
por: Shams Alizadeh, Narges, et al.
Publicado: (2015)

Dexmedetomidine vs Propofol as an Adjunct to Ketamine for Electroconvulsive Therapy Anaesthesia
por: Yeter, Tuğçe, et al.
Publicado: (2022)

Supportive text messages for patients with alcohol use disorder and a comorbid depression: a protocol for a single-blind randomised controlled aftercare trial
por: Hartnett, Dan, et al.
Publicado: (2017)

Low-dose ketamine does not improve the speed of recovery from depression in electroconvulsive therapy: a randomized controlled trial
por: Woolsey, Adrianna J., et al.
Publicado: (2021)

Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia
por: Aksay, Suna Su, et al.
Publicado: (2017)

Electroconvulsive therapy (ECT) with ketamine induction for catatonia in an HIV positive patient
por: Nel, Yvette, et al.
Publicado: (2023)

The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial
por: Knyahnytska, Yuliya, et al.
Publicado: (2022)

Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT)
por: Ekstrand, Joakim, et al.
Publicado: (2021)

Is ketamine–propofol mixture (ketofol) an appropriate alternative induction agent for electroconvulsive therapy?
por: Firouzian, Abolfazl, et al.
Publicado: (2013)

BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study
por: Huang, Xing-Bing, et al.
Publicado: (2020)

Keeping the living well
Publicado: (2015)

How to Keep Well
Publicado: (1890)

How to Keep Well
por: Evans, W. A.
Publicado: (1912)

How to Keep Well
Publicado: (1902)

Ketamine/propofol admixture (ketofol) at induction in the critically ill against etomidate (KEEP PACE trial): study protocol for a randomized controlled trial
por: Smischney, Nathan J, et al.
Publicado: (2015)

Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)
por: Trevithick, Liam, et al.
Publicado: (2015)

Comparative efficacy, cognitive effects and acceptability of electroconvulsive therapies for the treatment of depression: protocol for a systematic review and network meta-analysis
por: Nikolin, Stevan, et al.
Publicado: (2022)

Comparison of efficacy of ketamine versus thiopentone-assisted modified electroconvulsive therapy in major depression
por: Jagtiani, Amit, et al.
Publicado: (2019)

Comparison of efficacy of ketamine versus thiopentone-assisted modified electroconvulsive therapy in major depression
por: Jagtiani, Amit, et al.
Publicado: (2020)

Efficacy of ketamine, propofol, and dexmedetomidine for anesthesia in electroconvulsive therapy in treatment-resistant major depressive disorder patients: a double-blind randomized clinical trial
por: Modir, Hesameddin, et al.
Publicado: (2022)

How to Keep the Baby Well
Publicado: (1891)

How to Keep the Baby Well
Publicado: (1890)

Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study
por: Zheng, Wei, et al.
Publicado: (2021)

Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality
por: Sartorius, Alexander, et al.
Publicado: (2020)

The challenges of keeping clinicians unaware of their participation in a national, cluster-randomised, implementation trial
por: Kuo, Jex, et al.
Publicado: (2022)

Impact comparison of ketamine and sodium thiopental on anesthesia during electroconvulsive therapy in major depression patients with drug-resistant; a double-blind randomized clinical trial
por: Salehi, B., et al.
Publicado: (2015)

Negative results for ketamine use in severe acute bronchospasm: a randomised controlled trial
por: Nedel, Wagner L., et al.
Publicado: (2020)

Effectiveness of an eHealth self-management tool for older adults with multimorbidity (KeepWell): protocol for a hybrid effectiveness–implementation randomised controlled trial
por: Kastner, Monika, et al.
Publicado: (2021)

Ketamine Augmentation of Electroconvulsive Therapy: A Scoping Review of Dose-Dependent Effects in Major Depressive Disorder
por: Nagi, Tarika, et al.
Publicado: (2023)

Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study
por: Ryan, K M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f6ddt35hc8amfgr4ljr5fa70o6